GLP-1 Blood Tests for Women Aged 26–45 in South Africa: What to Discuss Before Treatment

Start with your health goals, not somebody else’s body

An appointment should not be a judgement about willpower. Write down what you want help with—such as your diabetes care, day-to-day health or the burden of managing weight—and what worries you about treatment. You do not need to compare yourself with another woman to deserve respectful care. A useful outcome may be a treatment plan, further investigation or a decision that medicine is not appropriate.

The test names to discuss

NICE’s UK assessment checklist includes the tests below depending on clinical circumstances; it explicitly allows relevant recent results. It is a clinical reference, not South African eligibility or funding policy.¹ Ask your prescriber which question each selected test will answer.

HbA1c is useful, but context matters

HbA1c reflects blood glucose over approximately three months and does not itself require fasting. Anaemia, altered red-cell turnover, pregnancy and some haemoglobin variants can affect interpretation. Tell the clinician about recent blood loss or transfusion and bring previous results. An unexpected result needs clinical interpretation; do not use a single number from an online chart to diagnose yourself.²

Pregnancy planning belongs in the appointment

Tell your prescriber whether pregnancy is possible, whether you are breastfeeding, and whether you hope to conceive. Ask whether a pregnancy test is needed and when it would be informative. A negative test today cannot rule out a future pregnancy. The MHRA’s UK guidance advises against GLP-1 use during pregnancy, while trying to conceive or breastfeeding; your South African prescriber should check the exact local product information and plan alternatives where needed.⁵

Tirzepatide has a specific oral-contraceptive precaution: the MHRA advises an additional barrier method or a non-oral method for four weeks after starting and after each dose increase. Discuss this before treatment; do not change or stop contraception without a plan. This precaution should not be assumed identical for every GLP-1 medicine.⁵

Do you need a large female hormone or vitamin package?

Age 26–45 alone is not an indication for a broad hormone, vitamin or fertility panel. Bring concerns such as heavy or irregular periods, persistent fatigue or dietary restrictions to the consultation rather than selecting tests from a marketing bundle. Ask what the clinician suspects, which targeted investigation would help, and whether the result would change care. The aim is an answer to a clinical question, not the longest possible laboratory request.

Taking the request to PathCare or another South African laboratory

PathCare publishes a local request form with referring-doctor and account information.³ We do not sell a PathCare package, quote its fees or imply a partnership. You can ask your clinician about PathCare or another local provider; confirm branch services directly.

1. Ask the prescriber to specify the tests and confirm whether previous results can be used.
2. Ask the laboratory for a written quote in rand, preparation instructions and any appointment requirements. Confirm medical-aid cover with your scheme rather than assuming payment.
3. Clarify fasting for the complete request. HbA1c alone does not require it, but another requested test may. Do not stop medicines unless your clinician instructs you.
4. Arrange who receives the results, who explains them and when you should follow up. Keep your own copy.

A normal panel is not medicine approval

SAHPRA’s recall warning about specified semaglutide and tirzepatide products illustrates why product verification is separate from patient testing.⁴ Ask your prescriber and pharmacist to verify the exact product and appropriate South African supply route. Normal results do not establish the quality, safety or legality of an online research product.

Leave the appointment with a written plan for follow-up, symptoms requiring help and whom to contact. You deserve clear explanations whether or not medicine forms part of that plan. The editorial illustration is AI-generated and does not depict an actual consultation.